MarketBeat aggregated analyst ratings for Altimmune, Inc., while Leerink Partners began coverage of the stock.

The entities involved

• Altimmune, Inc. →

  American biopharmaceutical company

  • X4 Pharmaceuticals and Altimmune, Inc. are small-cap healthcare companies trading on the Nasdaq stock exchange.Thu 14:20
• MarketBeat →

  American personal finance blog

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15
• Leerink partners →

  U.S. investment bank

  • Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52
  • A filing required by the SEC concerning McKesson Corporation shares, accompanied by analyst commentary.Sun 22:38

Related events

• Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.Jun 28
• MarketBeat aggregated analyst ratings on ENI stock on August 31, 2026.Aug 31
• MarketBeat summarized analyst ratings for Hooker Furnishings Corp. and Zepp Health Corporation.Sep 8
• MarketBeat aggregates analyst ratings and targets for JBT Marel Corporation.Aug 27
• MarketBeat reported an average stock rating for Superior Group of Companies.Sep 17